DISCONTINUED OPERATIONS

3 Months Ended

Sep. 30, 2017

Discontinued Operations and Disposal Groups [Abstract]

DISCONTINUED OPERATIONS

NOTE 4. DISCONTINUED OPERATIONS

On January 27, 2017, we sold certain of the assets and the business operations of our OMS division located in Beaverton Oregon. We sold the business to our long time general manager of the division. The sale was structured as an asset sale as disclosed in our Form 8-K filed with the SEC on January 30, 2017. The aggregate sales price received was $636,000, and no liabilities other than warranty obligations were assumed by the buyer. As a result of the sale, this division has been classified as a discontinued operation in conformity with applicable accounting guidance. Accordingly, unless otherwise indicated, OMS’s results have been reported as discontinued operations and removed from all financial discussions of continuing operations.

Operating results of the OMS division are as follows (in thousands):

	September 30, 2016
Revenues	$	283
Loss from discontinued operations:
Loss from discontinued operations, before taxes		(1	)
Income tax (expense) benefit		—
Net loss from discontinued operations	$	(1	)

The divestiture was completed in support of raising capital to invest in our core medical device product development efforts. The loss from discontinued operations consisted of direct revenues and direct expenses of the OMS business, including cost of revenues, as well as other fixed costs to the extent that such costs were eliminated as a result of the sale. The Company historically did not allocate corporate overhead to this division. Additionally, the OMS division has historically been the only division that was significant enough to require segment disclosures and as such, effective with this divestiture, we no longer require segment disclosure as our business is currently run.